Ocugen Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies to treat eye diseases | ![]() Asklepios BioPharmaceutical Asklepios BioPharmaceutical is engaged in the development and delivery of novel protein. | |
Founding Date | Founding Date 2013 | Founding Date 2001 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Malvern, US HQ | Locations Chapel Hill, US HQ Roslin, GB |
Employees | Employees 84425% increase | Employees 5172% increase |

Asklepios BioPharmaceutical is engaged in the development and delivery of novel protein.
View company